CHD1 dysregulation in cancer: bridging chromatin instability, therapy resistance, and immune evasion.

Saved in:
Bibliographic Details
Title: CHD1 dysregulation in cancer: bridging chromatin instability, therapy resistance, and immune evasion.
Authors: Kumar KSP; Department of Medical Genetics, JSS Medical College and Hospital, JSS-AHER, 570015, Mysuru, India, Karnataka. praveenkumarks@jssuni.edu.in., Jyothi MN; Department of Medical Genetics, JSS Medical College and Hospital, JSS-AHER, 570015, Mysuru, India, Karnataka., Prashant A; Department of Biochemistry, JSS Medical College and Hospital, JSS-AHER, Karnataka, 570015, Mysuru, India.
Source: Molecular biology reports [Mol Biol Rep] 2025 Apr 25; Vol. 52 (1), pp. 426. Date of Electronic Publication: 2025 Apr 25.
Publication Type: Journal Article; Review
Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-4978
DOI:10.1007/s11033-025-10536-w